<unk>  is a Gonadotropin-releasing Hormone (GnRH) agonist that is FDA approved for the treatment of locally confined carcinoma of the prostate, and palliative treatment of advanced carcinoma of the prostate.   Common adverse reactions include hot flashes, sexual dysfunction, decreased erections and lower urinary tract symptoms.
Goserelin
Buserelin
Proligeston
Gestodene
Sermorelin
Leuprolide
Anastrozole
Fosfestrol